SENTRY Antimicrobial Surveillance Program Asia-Pacific region and South Africa
DOI:
https://doi.org/10.33321/cdi.2003.27.23Keywords:
antimicrobial resistance surveillanceAbstract
The SENTRY Antimicrobial Surveillance Program was initiated in January 1997 and was designed to monitor the predominant pathogens and antimicrobial resistance for both nosocomial and community-acquired infections globally by using validated, reference-quality identification and susceptibility testing methods performed in a central laboratory. Consecutive bacterial or fungal isolates, deemed clinically significant by local criteria, are forwarded to the local reference laboratory from various study objectives. The major objectives include blood stream infections, community-acquired respiratory tract infections (Streptococcus pneumoniae, Haemophilus influenzae and Moraxella catarrhalis), pneumonias in hospitalised patients, skin and soft tissue infections, and urinary tract isolates from hospitalised patients. In 2001, special objectives were introduced to examine gastroenteritis pathogens and ß-haemolytic streptococcal isolates. Over 22 nations participate in SENTRY surveillance globally. The Women's and Children's Hospital, Adelaide has been the reference centre for the Asia-Pacific region and South Africa since 1998, and three other Australian institutions, from Brisbane, Perth, and Adelaide, are part of the global network. All isolates received from our region are tested against up to 29 antimicrobial agents using custom-made broth microdilution panels. The data generated from SENTRY allows Australia to compare our antimicrobial resistance patterns and trends with our regional neighbours. Commun Dis Intell 2003;27 Suppl:S61-S66.
Downloads
References
Turnidge J, Bell J, Collignon P. The battle against antibiotic resistance. Microbiology Australia 1996;17:27-31.
Jones RN. The emergent needs for basic research, education, and surveillance of antimicrobial resistance. Problems facing the report from the American Society for Microbiology Task Force on Antibiotic Resistance. Diagn Microbiol Infect Dis 1996;25:153-161.
Emori TG, Culver DH, Horan TC, Jarvis WR, White JW, Olson DR, et al. National nosocomial infections surveillance system (NNIS): description of surveillance methods. Am J Infect Control 1991;19:19-35.
Archibald L, Phillips L, Monnet D, McGowan JE, Tenover F, Gaynes R. Antimicrobial resistance in isolates from inpatients and outpatients in the United States: increasing importance of the intensive care unit. Clin Infect Dis 1997;24:211-215.
Diekema DJ, Pfaller MA, Turnidge J, Verhoef J, Bell J, Fluit AC, et al. Genetic relatedness of multidrug-resistant, methicillin (oxacillin)-resistant Staphylococcus aureus bloodstream isolates from SENTRY antimicrobial resistance surveillance centers worldwide, 1998. Microb Drug Resis 2000;6:213-221.
Turnidge JD, Bell JM. Methicillin-resistant Staphylococcus aureus evolution in Australia over 35 years. Microb Drug Resis 2000;6:223-229.
Diekema DJ, Pfaller MA, Schmitz FJ, Smayevski J, Bell JM, Jones RN, et al. Survey of infections due to Staphylococcus species: frequency of occurrence and antimicrobial susceptibility of isolates collected in the United States, Canada, Latin America, Europe and the western Pacific for the SENTRY Antimicrobial Surveillance Program, 1997-1999. Clin Infect Dis 2001;32 Suppl 2:S114-S132.
Bell JM, Turnidge JD, SENTRY APAC. High prevalence of oxacillin-resistant Staphylococcus aureus isolates from hospitalised patients in Asia-Pacific and South Africa: Results from the SENTRY Antimicrobial Surveillance Program, 1998-1999. Antimicrob Agents Chemother 2002;46:879-881.
Bell JM, Turnidge JD, Gales AC, Pfaller MA, Jones RN, the SENTRY APAC Study Group. Prevalence of extended spectrum beta-lactamase (ESBL)-producing clinical isolates in the Asia-Pacific region and South Africa: regional results from SENTRY Antimicrobial Surveillance Program, (1998-99). Diagn Microbiol Infect Dis 2002;42:193-198.
Bell JM, Turnidge JD, Jones RN, the SENTRY Regional Participants Group. Antimicrobial resistance trends in community-acquired respiratory tract pathogens in the Western Pacific Region and South Africa: report from the SENTRY Antimicrobial Surveillance Program, (1998-1999) including an in vitro evaluation of BMS284756. Int J Antimicrob Agents 2002;19:125-132.
Bell JM, Turnidge JD, Pfaller MA, Jones RN. In vitro assessment of gatifloxacin spectrum and potency tested against Haemophilus influenzae, Moraxella catarrhalis, and Streptococcus pneumoniae isolates from the Asia-Pacific component of the SENTRY Antimicrobial Surveillance Program (1998-1999). Diagn Microbiol Infect Dis 2002;43:315-318.
Turnidge JD, Bell JM, Biedenbach DJ, Jones RN. Pathogen occurrence and antimicrobial resistance trends among urinary tract infection isolates in the Asia-Western Pacific Region: Report from the SENTRY Antimicrobial Surveillance Program, 1998-1999. Int J Antimicrob Agents 2002;20:10-17.
National Committee for Clinical Laboratory Standards. Methods for dilution antimicrobial susceptibility tests for bacteria that grow aerobically; Approved Standard-Fifth Edition [M7-A5]. National Committee for Clinical Laboratory Standards, Wayne, Pennsylvania, 2000.
National Committee for Clinical Laboratory Standards. Performance standards for antimicrobial susceptibility testing; Twelfth informational supplement [M100-S12]. National Committee for Clinical Laboratory Standards, Wayne, Pennsylvania, 2002.
Bell JM, Turnidge JD, the SENTRY Western Pacific Plus Participants. Paper C2-1477 39th Interscience Conference on Antimicrobial Agents and Chemotherapy, 26-29 September 1999, San Francisco.
Downloads
Published
How to Cite
Issue
Section
Categories
License
Copyright (c) 2003 Communicable Diseases Intelligence
This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.
